Search Results - "Kagita, Sailaja"

Refine Results
  1. 1

    Role of Antioxidant Gene Polymorphisms in Risk and Prognosis of Chronic Myeloid Leukemia by Kagita, Sailaja, Digumarti, Raghunadharao, Gundeti, Sadhashivudu

    Published in Asian Pacific journal of cancer biology (21-03-2021)
    “…Introduction: We aimed to investigate the possible role of antioxidant enzyme polymorphisms CAT -21A/T (rs7943316), CAT -262C/T (rs1001179), GPX1 -198C/T…”
    Get full text
    Journal Article
  2. 2

    Correlation of C/EBPα expression with response and resistance to imatinib in chronic myeloid leukaemia by Kagita, Sailaja, Uppalapati, Srihari, Gundeti, Sadasivudu, Digumarti, Raghunadharao

    Published in Japanese journal of clinical oncology (01-08-2015)
    “…Altered differentiation is a common feature of haematopoietic malignancies with poor prognosis. CAAT/enhancer binding protein alpha (C/EBPα) is a key…”
    Get full text
    Journal Article
  3. 3

    Incidence of internal tandem duplications and D835 mutations of FLT3 gene in chronic myeloid leukemia patients from Southern India by Annamaneni, Sandhya, Kagita, Sailaja, Gorre, Manjula, Digumarti, Raghunadha Rao, Satti, Vishnupriya, Battini, Mohan Reddy

    Published in Hematology (Luxembourg) (01-04-2014)
    “…To screen two important FLT3 mutations (internal tandem duplication (ITD) and D835 point mutations) in chronic myeloid leukemia (CML) patients from Southern…”
    Get more information
    Journal Article
  4. 4
  5. 5
  6. 6

    Influence of Caspase-9 polymorphisms on the development of Chronic Myeloid Leukemia- A case-control study by Edathara, Prajitha Mohandas, Gorre, Manjula, Kagita, Sailaja, Cingeetham, Anuradha, Annamaneni, Sandhya, Digumarti, Raghunadharao, Satti, Vishnupriya

    Published in Gene (01-01-2019)
    “…Chronic Myeloid Leukemia (CML) is a myeloproliferative disorder, characterized by the overproduction of myeloid cells in all stages of maturation. It is…”
    Get full text
    Journal Article
  7. 7

    Impact of polymorphisms of TP53 Arg72Pro, excision repair cross-complementing Protein 1 Asn118Asn (C118T) and deletion in Intron 2 of BIM in chronic myeloid leukemia patients on imatinib treatment by Kagita, Sailaja, Gundeti, Sadasivudu, Digumarti, Raghunadharao

    “…Background: Imatinib (IM) results in durable responses in a large number of patients with chronic myeloid leukemia (CML). However, a substantial number…”
    Get full text
    Journal Article
  8. 8

    A Rare Toxicity to Chemotherapy by Vallathol, Dilip Harindran, Alapati, Neeharika, Kagita, Sailaja, Digumarti, Raghunadharao

    “…The use of chemotherapy is often limited by toxic side-effects caused to healthy cells. In general, most chemotherapy treatments cause DNA damage or stop cells…”
    Get full text
    Journal Article
  9. 9

    Abstract 3858: Genetic polymorphisms of DNA repair genes in the origin and progression of chronic myeloid leukemia by Gorre, Manjula, Mohandas, Prajitha Edathara, Kagita, Sailaja, Cingeetham, Anuradha, Vuree, Sugunakar, Annamaneni, Sandhya, Digumarti, Raghunadharao, Satti, Vishnupriya

    Published in Cancer research (Chicago, Ill.) (01-08-2015)
    “…Abstract Background: The origin of Chronic Myeloid Leukaemia (CML) involves the formation of Double Strand Breaks (DSBs) which are initially sensed by the…”
    Get full text
    Journal Article
  10. 10

    Incidence of Bcr-Abl kinase domain mutations in imatinib refractory chronic myeloid leukemia patients from South India by Kagita, Sailaja, Uppalapati, Srihari, Jiwatani, Sangeeta, Linga, Vijay Gandhi, Gundeti, Sadasivudu, Nagesh, Narayana, Digumarti, Raghunadharao

    Published in Tumor biology (01-07-2014)
    “…Mutations in the Bcr-Abl kinase domain (KD) are a major cause for acquired resistance to imatinib (IM) treatment and have been associated with progression and…”
    Get full text
    Journal Article
  11. 11

    Assessment of BCR-ABL1 fusion transcripts and their association with response to imatinib treatment in chronic myeloid leukemia patients by Kagita, Sailaja, Mamidi, Tulasi, Digumarti, Leela, Gundeti, Sadasivudu, Digumarti, Raghunadharao

    “…Objectives: BCR-ABL1 fusion transcripts with contrasting data on response to imatinib therapy have been reported from different parts of the world. Hence, the…”
    Get full text
    Journal Article
  12. 12

    Methylation status of CEBPA gene promoter in chronic myeloid leukemia by Annamaneni, Sandhya, Kagita, Sailaja, Gorre, Manjula, Digumarti, Raghunadha Rao, Satti, Vishnupriya, Battini, Mohan Reddy

    Published in Hematology (Luxembourg) (01-01-2014)
    “…CCAAT/enhancer binding protein alpha is one of the crucial transcription factors for myeloid cell development that has been found to be involved in…”
    Get more information
    Journal Article
  13. 13

    Association of XRCC5 VNTR polymorphism with the development of chronic myeloid leukemia by Gorre, Manjula, Mohandas, Prajitha Edathara, Kagita, Sailaja, Annamaneni, Sandhya, Digumarti, Raghunadharao, Satti, Vishnupriya

    Published in Tumor biology (01-02-2014)
    “…Double-strand breaks (DSBs) inducing agents influence the fidelity of DNA repair in both normal cells and leukemic cells, causing major genomic instability. In…”
    Get full text
    Journal Article
  14. 14

    Association of promoter polymorphisms of Fas –FasL genes with development of Chronic Myeloid Leukemia by Edathara, Prajitha Mohandas, Gorre, Manjula, Kagita, Sailaja, Vuree, Sugunakar, Cingeetham, Anuradha, Nanchari, Santhoshi Rani, Meka, Phanni bhushann, Annamaneni, Sandhya, Digumarthi, Raghunadha Rao, Satti, Vishnupriya

    Published in Tumor biology (01-04-2016)
    “…Chronic myeloid leukemia (CML) is a monoclonal myeloproliferative disorder of hematopoietic stem cells (HSCs), characterized by reciprocal translocation,…”
    Get full text
    Journal Article
  15. 15

    Association of XRCC1 gene polymorphisms with chronic myeloid leukemia in the population of Andhra Pradesh, India by Annamaneni, Sandhya, Gorre, Manjula, Kagita, Sailaja, Addepalli, Kasyap, Digumarti, Raghunadha Rao, Satti, Vishnupriya, Battini, Mohan Reddy

    Published in Hematology (Luxembourg) (01-05-2013)
    “…Chronic myeloid leukemia (CML), a clonal myeloproliferative disorder, is characterized primarily by the presence of chimeric BCR-ABL oncogene, and its…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Early molecular response in chronic myeloid leukemia patients predicts future response status by Kagita, Sailaja, Jiwtani, Sangeeta, Uppalapati, Srihari, Linga, Vijay Gandhi, Gundeti, Sadasivudu, Digumarti, Raghunadharao

    Published in Tumor biology (01-05-2014)
    “…Imatinib is the frontline therapy for chronic myeloid leukemia (CML) management. Most of the CML patients achieve major responses, but a proportion (nearly…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20